Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
Beauty
Analysis and advice on the fast-evolving beauty business.
Beauty Brands’ New Method for Driving Loyalty
Blockchain rewards platforms have scored big partnerships with brands like Ulta Beauty and Glossier in recent weeks, offering beauty brands a new way to connect with fans and reward loyalty.
Cult Gaia Gets Into Beauty With Fragrance Line
This week, the womenswear and accessories label is launching its first fragrance line. The three $228 scents are a major push towards its goal of becoming a full lifestyle brand.
Why Beauty Can’t Break Up With Anti-Ageing
Despite brands’ public promises to ditch the term and switch to more inclusive language, many shoppers still – secretly or publicly – want products with anti-ageing qualities.
The Business of Beauty Haul of Fame: Beauty and the Book Club
Your summer read may be doing double-duty as your latest source of makeup inspiration
The Dangers of ‘Casualising’ Injectables
From botulism to HIV, horror stories of minimally invasive cosmetic procedures have gained a national spotlight as consumers have turned to unlicensed practitioners.
To Restart Growth, Molton Brown Bets on Fine Fragrance
The British bath and body brand has been trying to grow its fragrance credentials since 2019. This week, it’s rolling out a brand refresh and new collection called Artists of Note, its boldest move yet.
The Business Opportunity in Gen-Z Bridal Beauty
As Gen-Z begins to head to the altar, their emerging bridal preferences can create fresh revenue-generating opportunities for beauty companies. But savvy marketing and deployment is needed to fully realise their potential.
Why Brands Are Inviting Customers on Influencer Trips
Lavish trips full of free swag are no longer exclusively for the high-follower-count elites.
The Business of Beauty Haul of Fame: Cash Is Thicker Than Water
For collect-em-all beauty shoppers, designer straws are becoming the new lip glosses.
The Debrief | How Tweens Took Over the Beauty Aisle
Senior correspondent Sheena Butler-Young speaks with Priya Rao, executive editor at The Business of Beauty, about tweens’ rising influence in beauty and how brands are catering to this young and increasingly influential demographic.
A Skincare Routine – for Your Dog
A $99 luxury dog perfume from Dolce & Gabbana ruffled furs, but it’s just one in a string of premium pet care products targeting beauty-savvy, wealthy shoppers.
With Ulta Beauty Entry, Ilia Wants to Go Mainstream
An early pioneer of 'clean' beauty, the premium cosmetics brand is jockeying to become a household name and conquer more categories and global territories.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.